non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC#838437ClinicalTrials.gov
• Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)#444864ClinicalTrials.gov
• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)#807635ClinicalTrials.gov
• Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.#15042NCBI PubMed Central
• Berberine Synergizes with Cisplatin via Inducing Apoptosis on A549 non-Small Cell Lung Cancer Cells#81200PhilArchive
• Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy#160336ClinicalTrials.gov
• Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer#161157HAL (France)
• Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction#184871ClinicalTrials.gov
• Prognostic and Therapeutic Significance of DPP4 in SMARCA4-Deficient Non-Small Cell Lung Cancer.#213983NCBI PubMed Central
• A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer#217032ClinicalTrials.gov
• Deep-Learning Serial CT Prediction of Survival in Immunotherapy-Treated Non–Small Cell Lung Cancer#370802HAL (France)
• MiracleNet: A Biologically Interpretable Machine Learning Model for Resected Non-small-cell Lung Cancer.#371403NCBI PubMed Central
• Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects#377410ClinicalTrials.gov
• Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy#377429ClinicalTrials.gov
• Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC#800323ClinicalTrials.gov
• Efficacy and Safety of Camrelizumab in Real-World Prospective Study#810352ClinicalTrials.gov
• Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC#811730ClinicalTrials.gov
• H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC#837255ClinicalTrials.gov
• Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.#154873ClinicalTrials.gov
• Phase II Iressa Versus Vinorelbine (INVITE)#835324ClinicalTrials.gov
• Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)#827828ClinicalTrials.gov
• QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer#832853ClinicalTrials.gov
• A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma#394772ClinicalTrials.gov
• Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer#363615ClinicalTrials.gov
• Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer#148740ClinicalTrials.gov
• Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial#28327ClinicalTrials.gov
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors#195313ClinicalTrials.gov
• Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy#806185ClinicalTrials.gov
• A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics#833363ClinicalTrials.gov
• A Retrospective Real-World Study Based on RATIONALE-307#426772ClinicalTrials.gov
• To Explore the Effect of Immune-induced Stereotactic Body Radiotherapy (SBRT) on Reversing Immunoresistance in Stage IIIc/IV Non-small Cell Lung Cancer (NSCLC)#290995ClinicalTrials.gov
• Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine#651122ClinicalTrials.gov
• Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial#262149HAL (France)
• Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT)#353288ClinicalTrials.gov
• A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)#451455ClinicalTrials.gov
• A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer#827890ClinicalTrials.gov
• KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors#414486ClinicalTrials.gov
• Loss of Insulin Receptor Substrates 1 and 2 Suppresses Kras-Driven Non-Small Cell Lung Cancer#643569Harvard DASH
• The lived experiences of individuals with early stage non-small cell lung cancer following lung surgery: A rapid ethnographic approach.#195978NCBI PubMed Central
• Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional Methods#373608ClinicalTrials.gov
• Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)#226862HAL (France)
• Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality#810639ClinicalTrials.gov
• Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC#158214ClinicalTrials.gov
• Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer#805388ClinicalTrials.gov
• Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity#831531ClinicalTrials.gov
• A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors#804465ClinicalTrials.gov
• A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens#426789ClinicalTrials.gov
• First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy#158205ClinicalTrials.gov
• A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients#184840ClinicalTrials.gov
• Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC#217007ClinicalTrials.gov